Claims against Dr Reddy's over Revlimid in US dismissed

Dr Reddy's Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medicine Revlimid, used in treatment of multiple myeloma have been dismissed.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Gh6HqjO
via IFTTT